*MEDICINE* - Palliative Haloperidol SC
Codelist metadata
- Coding system
- Pseudo BNF
- Coding system release
- unknown
- Author
- Vicky Speed
- Codelist ID
- user/speed-vm/medicine-palliative-haloperidol-sc
- Version ID
- 574ed60e
About
Description
User Requirements This codelist aims to identify haloperidol being used in the context of palliative care at the end of life. Medications are based on [Priority medicines for palliative and end of life care during a pandemic.]
This list covers formulations that could be given subcutaneously.
Methodology
Methodology Search Terms Haloperidol
Inclusion Criteria for Codes
Refers to haloperidol formulations that could be given subcutaneously.
Exclusion Criteria for Codes
Haloperidol formulations that are not for SC route (e.g. PO, depo injection including haloperidol decanoate)
Borderline Cases to Highlight Nil
Signed off by
- Vicky Speed, (May 31, 2022)
- Richard Croker, (May 31, 2022)
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
| code | term |
|---|---|
| 0402010J0AAACAC | Haloperidol 5mg/1ml solution for injection ampoules |
| 0402010J0BDAEAC | Haldol 5mg/1ml solution for injection ampoules |
| 0402010J0BEAGAC | Serenace 5mg/1ml solution for injection ampoules |